BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6188707)

  • 1. Modulation of human T lymphocyte functions by isoprinosine.
    Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
    Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
    Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
    Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.
    Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I
    J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro.
    Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K
    Nephron; 1987; 46(3):243-6. PubMed ID: 2442634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopotentiation of impaired lymphocyte functions in vitro by isoprinosine in prodromal subjects and AIDS patients.
    Tsang P; Lew F; O'Brien G; Selikoff IJ; Bekesi JG
    Int J Immunopharmacol; 1985; 7(4):511-4. PubMed ID: 2412972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprinosine-induced modulation of T-helper-cell subsets and antigen-presenting monocytes (Leu M3 + Ia +) resulted in improvement of T- and B-lymphocyte functions, in vitro in ARC and AIDS patients.
    Tsang PH; Sei Y; Bekesi JG
    Clin Immunol Immunopathol; 1987 Nov; 45(2):166-76. PubMed ID: 2444374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary characterization in mice of the effect of isoprinosine on the immune system.
    Vecchi A; Sironi M; Spreafico F
    Cancer Treat Rep; 1978 Nov; 62(11):1975-9. PubMed ID: 83191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of immune responses of aging hamsters by treatment with isoprinosine.
    Tsang KY; Fudenberg HH; Gnagy MJ
    J Clin Invest; 1983 Jun; 71(6):1750-5. PubMed ID: 6190840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of impaired B- and T-lymphocyte subsets and functions in vitro by isoprinosine in prodromal homosexuals and AIDS patients.
    Tsang PH; Zanjani MD; Warner N; Bekesi JG
    J Clin Lab Immunol; 1986 Aug; 20(4):159-65. PubMed ID: 2428980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isoprinosine on lymphocyte proliferation and natural killer cell activity following thermal injury.
    Singh H; Herndon DN
    Immunopharmacol Immunotoxicol; 1989; 11(4):631-44. PubMed ID: 2483407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of isoprinosine on natural killer cell activity of blood mononuclear cells in vitro and in vivo.
    Hersey P; Edwards A
    Int J Immunopharmacol; 1984; 6(4):315-20. PubMed ID: 6207121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro restoration of immune responses in aging humans by isoprinosine.
    Tsang KY; Pan JF; Swanger DL; Fudenberg HH
    Int J Immunopharmacol; 1985; 7(2):199-206. PubMed ID: 2409037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro study on the effects of isoprinosine on immune responses in cancer patients.
    Tsang KY; Fudenberg HH; Pan JF; Gnagy MJ; Bristow CB
    Int J Immunopharmacol; 1983; 5(6):481-90. PubMed ID: 6198297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency.
    Galbraith GM; Thiers BH; Fudenberg HH
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):224-30. PubMed ID: 6207216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of two immunopotentiators, Isoprinosine and NPT 15392, on murine T-cell differentiation and function.
    Ikehara S; Hadden JW; Good RA; Lunzer DG; Pahwa RN
    Thymus; 1981 Aug; 3(2):87-95. PubMed ID: 6170135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
    Morin A; Griscelli C; Daguillard F
    Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in pokeweed mitogen stimulated cultures of B and T cells.
    Hersey P; Bindon C; Bradley M; Hasic E
    Int J Immunopharmacol; 1984; 6(4):321-8. PubMed ID: 6207122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of isoprinosine, levamisole, muramyl dipeptide, and SM1213 on lymphocyte and macrophage function in vitro.
    Hadden JW
    Cancer Treat Rep; 1978 Nov; 62(11):1981-5. PubMed ID: 83192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor cell activity after isoprinosine treatment of lymphocytes from normal mice.
    Renoux G; Renoux M; Degenne D
    Int J Immunopharmacol; 1979; 1(3):239-41. PubMed ID: 95251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.